REEP3 Activators
Activation of REEP3 is intricately linked to the regulation of intracellular cyclic nucleotide concentrations and subsequent kinase activation. One mechanism by which the activity of REEP3 is increased involves the enhancement of adenylate cyclase activity, leading to elevated levels of cAMP within the cell. This surge in cAMP activates protein kinase A, a kinase that plays a pivotal role in phosphorylating and activating REEP3. Additionally, the inhibition of phosphodiesterases by specific compounds results in sustained cAMP and cGMP levels, which further supports a favorable environment for PKA-mediated activation of REEP3. Furthermore, the indirect effects of hormone-like substances that interact with G protein-coupled receptors also culminate in increased cAMP production. These signals converge on PKA, which then targets REEP3, enhancing its function in modulating receptor trafficking and signaling dynamics.
The activity of REEP3 can also be indirectly influenced by alterations in intracellular calcium levels and the associated activation of calcium-dependent kinases. For instance, the binding of certain alkaloids to specific receptors can lead to an influx of calcium, which subsequently activates calmodulin kinase, a kinase capable of phosphorylating and activating REEP3. Additionally, synthetic catecholamines and beta-adrenergic agonists that mimic the action of natural neurotransmitters can initiate a signaling cascade that ultimately results in increased cAMP levels and PKA activation, indirectly promoting the phosphorylation of REEP3.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
This diterpene activates adenylate cyclase, increasing cyclic AMP (cAMP) levels in cells. Elevated cAMP enhances protein kinase A (PKA) activity, which can lead to phosphorylation and activation of REEP3, ensuring its proper function in modulating receptor trafficking. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A nonspecific inhibitor of phosphodiesterases which prevents the breakdown of cAMP and cGMP, thereby sustaining their signaling. By maintaining high intracellular cAMP levels, IBMX indirectly enhances PKA activity, which can phosphorylate and activate REEP3. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
This hormone binds to adrenergic receptors leading to G protein activation and subsequent adenylate cyclase activation. The resulting increase in cAMP levels indirectly activates PKA, which may then phosphorylate and support the activation of REEP3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A synthetic catecholamine that activates beta-adrenergic receptors, increasing cAMP production. The rise in cAMP activates PKA, which could phosphorylate and enhance the activity of REEP3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
This selective phosphodiesterase-4 inhibitor prevents cAMP breakdown, resulting in elevated PKA activity. PKA can then phosphorylate REEP3, indirectly promoting its activation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 binds to its EP receptors, leading to an increase in cAMP levels. This, in turn, activates PKA, which may phosphorylate and facilitate the activation of REEP3. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
A phosphodiesterase inhibitor that increases intracellular cAMP levels. This elevation in cAMP can enhance PKA activity, which may then phosphorylate and activate REEP3. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
A selective inhibitor of phosphodiesterase-3 that increases cAMP levels in cells, indirectly promoting PKA-mediated phosphorylation and activation of REEP3. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Inhibits phosphodiesterase-3, leading to increased cAMP and subsequent activation of PKA. Activated PKA can phosphorylate and promote the functional activity of REEP3. | ||||||
Dobutamine | 34368-04-2 | sc-507555 | 100 mg | $295.00 | ||
A beta-1 adrenergic agonist that leads to increased cAMP production. This elevated cAMP level can enhance PKA activity, which might then activate REEP3 by phosphorylation. | ||||||